Angeles Mecate‐Zambrano

Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine

Sebastian Schloer, Linda Brunotte, Jonas Goretzko et al. · Emerging Microbes & Infections · 2020 · 152 citations · Full text

Immunology, Pharmacotherapy, Fiasma Group +22

Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro

Sebastian Schloer, Linda Brunotte, Angeles Mecate‐Zambrano et al. · British Journal of Pharmacology · 2021 · 110 citations · Full text

Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages

Katja Hönzke, Benedikt Obermayer, Christin Mache et al. · European Respiratory Journal · 2022 · 58 citations · Full text

SARS-CoV-2 infects and replicates in photoreceptor and retinal ganglion cells of human retinal organoids

Yotam Menuchin-Lasowski, André Schreiber, Aarón Lecanda et al. · Stem Cell Reports · 2022 · 54 citations · Full text

Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro

Linda Brunotte, Shuyu Zheng, Angeles Mecate‐Zambrano et al. · Pharmaceutics · 2021 · 42 citations · Full text

Drug Interaction, Medicine, Adenosine Kinase +13